Nurse Practitioner, Family · Fairmont, NC
NPI
1790784619
Since 2005
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
101 N Walnut St
Fairmont, NC, 28340
Phone (910) 628-0655
Groups this clinician bills Medicare through
Medicare paid, 2024
$160K
1,521 services
Medicare patients, 2024
153
Average age 68
Drug cost, 2024
$1.3M
6,504 prescriptions
Company payments, 2025
$387
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diana M McKeithan was code 99214 (office e&m - established), 533 times for 136 patients. In total Diana M McKeithan billed 1,521 services in 9 codes, and Medicare paid $160K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 533 | 136 | $69.24 | $37K |
| 80307 Drug Tests | Office | 481 | 142 | $60.90 | $29K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 191 | 67 | $153.46 | $29K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 169 | 52 | $194.77 | $33K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 112 | 56 | $241.98 | $27K |
| 99205 Office E&M - New | Office | 26 | 26 | $121.57 | $3,161 |
By year: 2022 $185K for 1,952 services; 2023 $168K for 1,611 services; 2024 $160K for 1,521 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 481 | 142 | $60.90 | $29K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 191 | 67 | $153.46 | $29K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 169 | 52 | $194.77 | $33K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 112 | 56 | $241.98 | $27K |
Medicare prescription drug claims, 2024
In 2024, the drug Diana M McKeithan prescribed most often to Medicare patients was Oxycodone Hcl, with 1,137 prescriptions and refills. In total Diana M McKeithan wrote 6,504 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 1,137 | 1,137 | 151 | $18K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,032 | 1,032 | 136 | $142K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 816 | 816 | 112 | $23K |
| Xtampza Er Oxycodone Myristate | 512 | 512 | 62 | $418K |
| Gabapentin Generic | 337 | 356 | 62 | $3,857 |
| Morphine Sulfate Er Morphine Sulfate | 249 | 249 | 32 | $7,870 |
| Cyclobenzaprine Hcl Generic | 236 | 239 | 42 | $2,045 |
| Tramadol Hcl Generic | 215 | 215 | 37 | $1,708 |
| Pregabalin Generic | 194 | 201 | 32 | $3,420 |
| Diclofenac Sodium Generic | 130 | 149 | 42 | $55K |
| Belbuca Buprenorphine Hcl | 130 | 130 | 21 | $101K |
| Buprenorphine Generic | 125 | 125 | 31 | $39K |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 121 | 121 | 23 | $16K |
| Methocarbamol Generic | 103 | 107 | 16 | $1,832 |
| Methadone Hcl Generic | 103 | 103 | Under 11 | $1,957 |
Brand drugs: 1,178 claims; generic drugs: 5,326 claims; opioid claims: 4,469.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diana M McKeithan $387 ($387 in general payments such as food, travel and fees) from 10 companies. The largest payer was Collegium Pharmaceutical, Inc. with $152.
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. COLL | 10 | $152 |
| Protega Pharmaceutials Inc | 3 | $45.33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $37.51 |
| Braeburn Inc. | 2 | $34.69 |
| Forte Bio-Pharma LLC | 1 | $23.83 |
| Abbvie Inc. ABBV | 1 | $21.18 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $19.98 |
| Valinor Pharma, LLC | 1 | $19.23 |
| Virtus Pharmaceuticals LLC | 1 | $17.24 |
| Indivior Inc. INDV | 1 | $16.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.